🇰🇷 Sirturo in South Korea

Sirturo (bedaquiline) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Sirturo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in South Korea

Frequently asked questions

Is Sirturo approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Sirturo in South Korea?

Janssen Therap is the originator. The local marketing authorisation holder may differ — check the official source linked above.